Microbiome and Polycystic Ovaries

Condition(s) studied

Investigational drug(s) / intervention(s)

Dietary recommendations: Fruit, vegetables, legumes (e.g. lentils and beans), nuts and whole grains (e.g. unprocessed maize, millet, oats, wheat and brown rice). At least 400 g (i.e. five portions) of fruit and vegetables per day excluding potatoes, sweet potatoes, cassava and other starchy roots. Less than 10% of total energy intake from free sugars Less than 30% of total energy intake from fats. Unsaturated fats (found in fish, avocado and nuts, and in sunflower, soybean, canola and olive oils) are preferable to saturated fats. Less than 5 g of salt (equivalent to about one teaspoon) per day.

Oral contraceptive pills: Hormonal treatment

Metformin: Insulin resistance treatment

Study summary

Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder among women in reproductive age with an estimated prevalence of 5% to 19.5%. It is a chronic complex syndrome with psychological (depression and anxiety), reproductive and metabolic abnormalities. The etiology seems to be multifactorial. Lately, interest regarding the association between PCOS women and gut macrobiotic have been emerged. Hyperandrogenism was correlated with those changes in the microbiota which reflects the fact that the microbiome can influence the development and pathology of PCOS .

Therefore, aim of this study is to explore the diversity and alternations of the vaginal and the gut microbiome in patients with PCOS during common therapeutic interventions and connect them to different phenotypes of the syndrome.

Eligibility

Primary outcome measure(s)

• Vaginal and gut microbiota composition before and after intervention recommended and in comparison to women without PCOS. — Through study completion, an estimated period of 1 year
  Evaluated by PCR ( ng/microl)

Trial sites (1)

On this site

More Sheba Medical Center trials in Israel

Other trials for the same condition